Organon & Co.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OGN research report →
About the company
Organon & Co. , a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive.
- CEO
- Joseph T. Morrissey Jr.
- IPO
- 2021
- Employees
- 10,000
- HQ
- Jersey City, NJ, US
Price Chart
- Market Cap
- $3.56B
- P/E
- 14.26
- P/S
- 0.58
- P/B
- 3.91
- EV/EBITDA
- 7.96
- Div Yield
- 0.59%
- Gross Margin
- 53.11%
- Op Margin
- 19.23%
- Net Margin
- 3.99%
- ROE
- 29.87%
- ROIC
- 5.16%
- Revenue
- $6.22B · -2.92%
- Net Income
- $187.00M · -78.36%
- EPS
- $0.72 · -78.57%
- Op Income
- $1.28B
- FCF YoY
- -8.50%
- 52W High
- $13.60
- 52W Low
- $5.69
- 50D MA
- $13.17
- 200D MA
- $9.24
- Beta
- 1.54
- Avg Volume
- 8.41M
Get TickerSpark's AI analysis on OGN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 26 | Sharp Shalini | other | 17,857.143 |
| Jun 12, 26 | Sequeira Ramona | other | 17,857.143 |
| Jun 12, 26 | Patton Cynthia M | other | 17,857.143 |
| Jun 12, 26 | Ozuah Philip | other | 17,857.143 |
| Jun 12, 26 | Leone Deborah R | other | 17,857.143 |
| Jun 12, 26 | LAZARUS ROCHELLE B | other | 17,857.143 |
| Jun 12, 26 | Gayle Helene D | other | 17,857.143 |
| Jun 12, 26 | Ezekowitz Alan | other | 17,857.143 |
| Jun 12, 26 | ESSNER ROBERT | other | 17,857.143 |
| May 6, 26 | Holzbaur Lynette | other | 45.939 |
Our OGN coverage
Recent articles, reports, and earnings notes.
No research on OGN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OGN report →Similar companies
Peers in the same neighborhood.